News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
224 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (258)
2 (248)
3 (119)
4 (1)
5 (30)
6 (211)
7 (196)
8 (187)
9 (224)
10 (123)
11 (42)
12 (30)
13 (282)
14 (254)
15 (234)
16 (227)
17 (162)
18 (1)
19 (7)
20 (203)
21 (157)
22 (183)
23 (103)
24 (13)
25 (1)
27 (71)
28 (66)
29 (85)
30 (85)
31 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
FDA
Reata Stock Takes a Blow as FDA Panel Voted Down Alport Syndrome Drug
Shares of Reata Pharmaceuticals have plunged nearly 40% in premarket trading after an FDA advisory panel recommended against the approval of its Alport syndrome disease treatment, bardoxolone.
December 9, 2021
·
2 min read
·
Alex Keown
Policy
Key Takeaways from Elizabeth Holmes’ Seven-Day Testimony
Throughout her defense, she cast blame for Theranos’ troubles on her former partner and lover, Ramesh “Sunny” Balwani, as well as subordinates who she claimed misled her.
December 9, 2021
·
3 min read
·
Alex Keown
Research Roundup: Controlling Blood Glucose Levels Decreases Cancer Risk and More
Cancer cells, because of their high metabolism and rapid growth, use up a lot of energy, which is supplied in the body by glucose, or blood sugar.
December 9, 2021
·
5 min read
·
Mark Terry
Business
Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds
The cash came rolling in for four biopharma companies Thursday morning, with collective Series A rounds totaling more than $125 million.
December 9, 2021
·
3 min read
·
Vanessa Doctor, RN
Career Advice
Signs That You Should or Shouldn’t Switch Your Job
Deciding on when to switch your job can be a difficult decision to make.
December 9, 2021
·
2 min read
·
Brandi Marcene
Business
BioSpace Movers & Shakers, Dec. 10
As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.
December 9, 2021
·
8 min read
·
Alex Keown
Business
COVID-19 Has Brought out the Best – and Worst – in Humanity
A TikTok video went “viral” in November, claiming that vaccine regretters should take complex “detox” baths featuring ingredients such as borax.
December 9, 2021
·
6 min read
·
Heather McKenzie
Drug Development
China Puts Renewed Focus on Monoclonal Antibodies in COVID-19 Fight
Researchers in China are busy developing several treatments, combining vaccines and drugs for COVID-19, and also working on monoclonal antibodies treatment.
December 9, 2021
·
8 min read
·
BioSpace Editorial Staff
Drug Development
Health Officials and Vaccine Makers Quibble Over Approach to Omicron Variant
Pfizer and BioNTech reported laboratory assays indicating that three doses of their mRNA COVID-19 vaccine are effective against the new COVID-19 variant, Omicron.
December 9, 2021
·
4 min read
·
Mark Terry
Policy
Reuters Investigation Points to J&J Coverup for Diabetes Drug Risk
Reuters alleges Johnson & Johnson knew of the ketoacidosis risk of its diabetes drug Invokana but covered it up.
December 9, 2021
·
3 min read
·
Mark Terry
1 of 23
Next